References
- Myers R R, Wagner R, Sorkin L S. Hyperalgesic actions of cytokines on peripheral nerves. Cytokines and Pain, L R Watkins, S F Maier. Birkhäuser, Basel 1999; 133–158
- Janig W, Baron R. Complex regional pain syndrome: mystery explained?. Lancet Neurol 2003; 2: 687–697
- Loeser J D. Economic implications of pain management. Acta Anaesthesiol Scand 1999; 43: 957–959
- Jacobson L, Mariano A J. General considerations of chronic pain. Lippincott Williams & Wilkins, Philadelphia 2001
- Reginster J Y, Khaltaev N G. Introduction and WHO perspective on the global burden of musculoskeletal conditions. Rheumatol (Oxford) 2002; 1(Suppl. 41)1–2
- van Tulder M, Koes B, Bombardier C. Low back pain. Best Pract Res Clin Rheumatol 2002; 16: 761–775
- Cervero F, Laird J M. From acute to chronic pain: Mechanisms and hypotheses. Prog Brain Res 1996; 110: 3–15
- Bonica J J. General consideration of chronic pain. The management of pain, J J Bonica. Lea & Febiger, Philadelphia 1990; 241–254
- Aguggia M. Neurophysiology of pain. Neurol Sci 2003; 24(Suppl. 2)S57–S60
- Merskey H, Bogduk N. Classification of chronic pain: Descriptions of chronic pain syndromes and definitions of pain terms. 2nd ed. IASP Press, Seattle, WA 1994
- Zeltser R, Seltzer Z. A practical guide for the use of animal models in the study of neuropathic pain. Touch, temperature and pain in health and disease: Mechanisms and assessments, J Boivie, P Hansson, U Linblom. IASP Press, Seattle, WA 1994; 295–338
- Kontinen V K. Spinal pharmacology of pain: Actions and interactions of μ-opioids, α-adrenergic agonists and neuropeptide FF in different models of pain in rats. Helsinki 1998; 24, ISBN 952 90 9626 2;
- Watkins L R, Maier S F. Beyond neurons: Evidence that immune and glial cells contribute to pathological pain states. Physiol Rev 2002; 82: 981–1011
- Enggaard T P, Klitgaard N A, Gram L F, Arendt-Nielsen L, Sindrup S H. Specific effect of venlafaxine on single and repetitive experimental painful stimuli in humans. Clin Pharmacol Ther 2001; 69: 245–251
- Hoitsma E, Reulen J P, de Baets M, Drent M, Spaans F, Faber C G. Small fiber neuropathy: A common and important clinical disorder. J Neurol Sci 2004; 227: 119–130
- Koltzenburg M. Classification of neuropathic pain. Pain 2002 – An updates review: Refresher Course Syllabus, M A Giamberardino. IASP Press, Seattle, WA 2002; 149–151
- Ossipov M H, Lai J, Malan T P, Jr, Porreca F. Spinal and supraspinal mechanisms of neuropathic pain. Ann NY Acad Sci 2000; 909: 12–24
- Patten J. Neurological differential diagnosis. Springer Verlag. 1995
- Yasuda H, Terada M, Maeda K, Kogawa S, Sanada M, Haneda M, Kashiwagi A, Kikkawa R. Diabetic neuropathyandnerve regeneration. Prog Neurobiol 2003; 69: 229–285
- Schmader K E. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain 2002; 18: 350–354
- Luciano C A, Pardo C A, McArthur J C. Recent developments in the HIV neuropathies. Curr Opin Neurol 2003; 16: 403–409
- Vielhaber A, Portenoy R K. Advances in cancer pain management. Hematol Oncol Clin North Am 2002; 16: 527–541
- Siddall P J, Taylor D A, Cousins M J. Classification of painfollowing spinal cord injury. Spinal Cord 1997; 35: 69–75
- Backonja M M. Anticonvulsants (antineuropathics) for neuropathic pain syndromes. Clin J Pain 2000; 16: S67–S72
- Bennett G J. Neuropathic pain: An overview. Molecular Neurobiology of pain. IASP Press, Seattle, WA 1997
- Asbury A K. Disorders of nerve and muscle. Harrinson's principles of internal medicine, E Harrinson, Braunwald. McGraw-Hill, New York 1998; 2457–2469
- Attal N. Chronic neuropathic pain: Mechanisms and treatment. Clin J Pain 2000; 16: S118–S130
- Hansson P. Possibilities and potential pitfalls of combined bedside and quantitative somatosensory analysis in pain patients. Touch, temperature and pain in health and disease: Mechanisms and assessments, progress in pain research and management, U Lindblom. IASP Press, Seattle, WA 1994; 113–132
- Korovessis P, Dimas A, Lambiris E. The significance of correlation of radiographic variables and MOS short-form health survey for clinical decision in symptomatic low backpain patients. Stud Health Technol Inform 2002; 91: 325–331
- Mao J, Chen L L. Systemic lidocaine for neuropathic pain relief. Pain 2000; 87: 7–17
- McLachlan E M, Janig W, Devor M, Michaelis M. Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglia. Nature 1993; 363: 543–546
- Woolf C J, Mannion R J. Neuropathic pain: Aetiology, symptoms, mechanisms and management. Lancet 1999; 353: 1959–1964
- Bredt D S, Nicoll R A. AMPA receptor trafficking at excitatory synapses. Neuron 2003; 40: 361–379
- Woolf C J, Thompson S W. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 1991; 44: 293–299
- Woolf C J, Doubell T P. The pathophysiology of chronic pain-increased sensitivity to low threshold A beta-fibre inputs. Curr Opin Neurobiol 1994; 4: 525–534
- Neumann S, Doubell T P, Leslie T, Woolf C J. Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature 1996; 384: 360–364
- Reynolds M L, Woolf C J. Reciprocal Schwann cell-axon interactions. Curr Opin Neurobiol 1993; 3: 683–693
- Muller H W, Stoll G. Nerve injury and regeneration: Basic insights and therapeutic interventions. Curr Opin Neurol 1998; 11: 557–562
- Watkins L R, Milligan E D, Maier S F. Glial proinflammatory cytokines mediate exaggerated pain states: Implications for clinical pain. Adv Exp Med Biol 2003; 521: 1–21
- Dinarello C A. Overview of inflammatory cytokines and their role in pain. Cytokines and Pain, L R Watkins, S F Maier. Birkhäuser Verlag, Basel 1999; 1–19